Figure 2.

(A) Distribution of VIM_me and miR663a_me levels in the Testing Cohort, composed by healthy donors (HD; n = 24) and bladder carcinoma (BlCa; n = 27) urine samples. Mann-Whitney U test, **** p < 0.0001. Median is represented by the red line. (B) Receiver operator characteristic (ROC) curve evaluating the performance of the VIM_me-miR663a_me panel for the identification of BlCa in urine samples of the Testing Cohort. (AUC—Area under the curve; CI—Confidence interval; ACTB—Beta-Actin; VIM—Vimentin).